RLAY relaytx.com Net earnings per share growth forecast for next year

Corporate company logo of Relay Corp (RLAY)

Relay Therapeutics (RLAY) implements digital drug design, reducing chemical and resource consumption in accordance with ESG principles. Strategic contracts with pharmaceutical behemoths ensure financial stability and positive FCF. On GURU.Markets, this linear chart of projected earnings per share for n+1, where -1.90 indicates the current level, highlights the company's technological lead driven by its unique AI protein analysis platform.

RLAY: Relay Therapeutics Inc Net earnings per one share growth forecast for next year 07/04/2022 - 11/12/2026

Financial and market metric breakdowns for relaytx.com (RLAY)

- share price and consensus valuation forecast:
Stock Price Relay Pharma|RLAY - Analyst Consensus Forecast
- market capitalization data:
Market Value Relay Therapeutics|RLAY - Value Adjusted for Debt and Cash
- company book value details:
Book Value per Share Relay Therapeutics|RLAY - Book Value of Business|Market Capitalization to Book Value Ratio relaytx.com|RLAY - Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Relay Therapeutics|RLAY - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Relay Therapeutics, Inc.|RLAY - Company Cumulative Debt|Debts to Book Capitalization Relay Therapeutics|RLAY - Company Long-Term Indebtedness|Company Current Liabilities Relay Therapeutics|Quick Liquidity Indicator relaytx.com
- earnings and valuation multiples information:
RLAY - Profit After Payment of Taxes|Projected Future Earnings Relay Therapeutics|RLAY - Company Value to Net Income|Forward P/E Multiple Relay Therapeutics|RLAY - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Relay Therapeutics|RLAY - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Relay Therapeutics|RLAY - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months relaytx.com|RLAY - Earnings per share trend in current year|Expected earnings per share growth for next year Relay Therapeutics
Fundamental company analysis:Relay Pharma, RLAY
Brand item of relaytx.com

Investors utilize this indicator to assess capitalization potential through the lens of future earnings per share. The metric aggregates analyst consensus net income forecasts, reflecting the efficiency of Relay Therapeutics (RLAY) digital drug design—which reduces chemical reagent costs and accelerates time-to-market—within the adjustments of target earnings per share estimates.

Competing companies

GMAB (Genmab US) - Earnings growth forecast for next year|Earnings growth forecast for next year Exelixis Inc.|Net earnings per share growth forecast for next year Nuvalent, Inc. (NUVL)|KYMR (kymeratx.com) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences, Inc.)|Net earnings per one share growth forecast for next year Enliven Therapeutics Inc|ORIC Pharma - Earnings growth forecast for next year|Expected net earnings per share growth next year Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Expected earnings per share growth for next year|VSTM: Projected earnings per share increase next year|GLUE (Monte Rosa Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Cullinan Oncology CGEM|Earnings growth forecast for next year IMRX|C4 Therapeutics Corp - Projected earnings per share growth rate for next year|Black Diamond - Expected earnings per share growth for next year|Expected earnings per share trend next year RPTX|PMVP: Expected earnings per share growth for next year|Karyopharm Therapeutics - Projected earnings per share increase next year|PPCB: Earnings growth forecast for next year|Cyclacel - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Aileron ALRN|Net earnings per share growth forecast for next year Blueprint Medicines (BPMC)|GLYC (glycomimetics.com) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks)